Who is working on Malaria Vaccine?

Several organizations and research institutions are actively working on malaria vaccines, including the University of Oxford, the Walter Reed Army Institute of Research, and the pharmaceutical company GlaxoSmithKline. Notably, the RTS,S/AS01 vaccine, developed by GSK and implemented in pilot programs in Africa, is one of the first to receive a recommendation for widespread use. Additionally, the PATH Malaria Vaccine Initiative is collaborating with various partners to advance new vaccine candidates in clinical trials. Ongoing research continues to explore innovative approaches to enhance vaccine efficacy and accessibility.